Etalocib
|
|
- CAS號:
- 161172-51-6
- 英文名:
- Etalocib
- 英文別名:
- VML 295;LY293111;Etalocib;Etalocib(LY293111);LY293111 Exclusive;YFIZRWPXUYFCSN-UHFFFAOYSA-N;2-(3-(3-((5-Ethyl-4'-fluoro-2-hydroxy-[1,1'-biphenyl]-4-yl)oxy)propoxy)-2-propylphenoxy)benzoic acid;2-(3-(3-((5-Ethyl-4'-fluoro-2-hydroxy-[1,1'-biphenyl]-4-yl)oxy)propoxy)-2-propylphenoxy)benzoic acid;Benzoic acid, 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]-;antiinflammatory,LY 293111,VML-295,VML 295,inhibit,LY-293111,Etalocib,Pulmonary,Leukotriene Receptor,Apoptosis,Inhibitor,asthma,bronchiectasis
- 中文名:
- Etalocib
- 中文別名:
- 化合物ETALOCIB;LY293111,白三烯 (LTB4) 受體的拮抗劑;2-[2-丙基-3-[3-[2-乙基-4-(4-氟苯基)-5-羥基苯氧基]丙氧基]苯氧基]苯甲酸;2-(3-(3-((5-乙基-4'-氟-2-羥基-[1,1'-聯(lián)苯]-4-基)氧基)丙氧基)-2-丙基苯氧基)苯甲酸;2-(3-(3-((5-乙基-4'-氟-2-羥基-[1,1'-聯(lián)苯]-4-基)氧基)丙氧基)-2-丙基苯氧基)苯甲酸
- CBNumber:
- CB61856046
- 分子式:
- C33H33FO6
- 分子量:
- 544.61
- MOL File:
- 161172-51-6.mol
|
|
|
Etalocib化學(xué)性質(zhì)
-
熔點:
-
68-70 °C(Solv: acetonitrile (75-05-8))
-
|
-
沸點:
-
656.8±55.0 °C(Predicted)
-
|
-
密度:
-
1?+-.0.06 g/cm3(Predicted)
-
|
-
儲存條件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO:98.5(Max Conc. mg/mL);173.85(Max Conc. mM)
-
|
-
形態(tài):
-
Solid
-
|
-
酸度系數(shù)(pKa):
-
3.32±0.36(Predicted)
-
|
-
顏色:
-
White to off-white
-
|
Etalocib性質(zhì)、用途與生產(chǎn)工藝
Etalocib (LY293111) 是具有口服活性的白三烯 (LTB4) 受體的拮抗劑,抑制 [3H]LTB4 結(jié)合的Ki 值為 25 nM. Etalocib (LY293111) 抑制LTB4 誘導(dǎo)的鈣動員的 lC50 值為 20 nM。Etalocib (LY293111) 可誘導(dǎo)凋亡。
Etalocib (LY293111) elicits a concentration-dependent inhibition of LTB
4
induced CD11b up-regulation.
Etalocib (LY293111) is an extremely potent and selective antagonist of human neutrophil function in vitro.
Etalocib (LY293111, 250 and 500 nM, 24-72 h) induces apoptosis and inhibits proliferation in human pancreatic cancer cells.
Cell Proliferation Assay
Cell Line:
|
MiaPaCa-2 and AsPC-1 human pancreatic cancer cells.
[3]
|
Concentration:
|
500 nM.
|
Incubation Time:
|
24, 48, and 72 h.
|
Result:
|
Caused both a concentration-dependent and time-dependent inhibition of thymidine incorporation in both MiaPaCa-2 and AsPC-1 human pancreatic cancer cells.
|
Apoptosis Analysis
Cell Line:
|
MiaPaCa-2 and AsPC-1 human pancreatic cancer cells.
|
Concentration:
|
250 and 500 nM.
|
Incubation Time:
|
24 h.
|
Result:
|
Induced apoptosis in human pancreatic cancer cells.
|
Etalocib (LY293111) produces a dose-related inhibition of acute leukotriene B
4
-induced airway obstruction when administered i.v. (ED
50
=14 μg/kg) or p.o. (ED
50
=0.4 mg/kg).
Etalocib (LY293111, 10 mg/kg) inhibits A23187-induced lung inflammatory changes at 1 h.
Etalocib (LY293111, 250 mg/kg/day, orally) inhibits growth of human pancreatic cancer xenografts in athymic mice.
Animal Model:
|
Guinea pigs.
|
Dosage:
|
1-10 mg/kg.
|
Administration:
|
Orally once.
|
Result:
|
A single 1 mg/kg oral dose inhibited excised lung gas volume increases by 76.7±7.1% (n=4, P<0.002) when given 8 h prior to leukotriene B
4
challenge, and 28.6±20.3% (n=4, NS) when given 24 h before challenge.
Had no effect (10 mg/kg) on pulmonary gas trapping at 1 h or 2 h after A23187 challenge. However, at 4 h, the pulmonary gas trapping response was significantly less than that of vehicle-treated controls and not different from sham values. The 10 mg/kg dose inhibited A23187-induced lung inflammatory changes at 1 h, but was without effect at 2 h or 4 h after challenge.
|
Etalocib
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS編號 | 包裝 | 價格 |
---|
2024/11/08 | HY-13628 | Etalocib | | 1 mg | 1500元 |
2024/11/08 | HY-13628 | Etalocib Etalocib | 161172-51-6 | 5mg | 3300元 |
161172-51-6, Etalocib 相關(guān)搜索:
- 抑制劑
- 合成有機化合物配體
- C33H33FO6
- 2-(3-(3-((5-乙基-4'-氟-2-羥基-[1,1'-聯(lián)苯]-4-基)氧基)丙氧基)-2-丙基苯氧基)苯甲酸
- 2-[2-丙基-3-[3-[2-乙基-4-(4-氟苯基)-5-羥基苯氧基]丙氧基]苯氧基]苯甲酸
- LY293111,白三烯 (LTB4) 受體的拮抗劑
- 化合物ETALOCIB
- 2-(3-(3-((5-乙基-4'-氟-2-羥基-[1,1'-聯(lián)苯]-4-基)氧基)丙氧基)-2-丙基苯氧基)苯甲酸
- 161172-51-6
- 2-(3-(3-((5-Ethyl-4'-fluoro-2-hydroxy-[1,1'-biphenyl]-4-yl)oxy)propoxy)-2-propylphenoxy)benzoic acid
- antiinflammatory,LY 293111,VML-295,VML 295,inhibit,LY-293111,Etalocib,Pulmonary,Leukotriene Receptor,Apoptosis,Inhibitor,asthma,bronchiectasis
- Etalocib(LY293111)
- YFIZRWPXUYFCSN-UHFFFAOYSA-N
- LY293111 Exclusive
- Benzoic acid, 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]-
- 2-(3-(3-((5-Ethyl-4'-fluoro-2-hydroxy-[1,1'-biphenyl]-4-yl)oxy)propoxy)-2-propylphenoxy)benzoic acid
- VML 295
- LY293111
- Etalocib